Compounds > pyrazines
Page last updated: 2024-08-21

pyrazines and pyridostigmine bromide

pyrazines has been researched along with pyridostigmine bromide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lanzi, R; Monti, LD; Pontiroli, AE; Pozza, G; Sandoli, E1
Alvarez, CV; Casanueva, FF; Cordido, F; Dieguez, C; Peino, R; Peñalva, A2

Trials

3 trial(s) available for pyrazines and pyridostigmine bromide

ArticleYear
Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin.
    The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:2

    Topics: Adult; Fatty Acids, Nonesterified; Feedback; Growth Hormone; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypolipidemic Agents; Hypothalamus; Lipolysis; Male; Pyrazines; Pyridostigmine Bromide; Somatostatin

1991
Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:3

    Topics: Adolescent; Adult; Drug Synergism; Fatty Acids, Nonesterified; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypolipidemic Agents; Male; Oligopeptides; Pyrazines; Pyridostigmine Bromide; Reference Values

1996
Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:3

    Topics: Adolescent; Adult; Fatty Acids, Nonesterified; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypolipidemic Agents; Male; Middle Aged; Obesity; Oligopeptides; Pyrazines; Pyridostigmine Bromide

1996